Jump to any asset
850 assets, updated daily
As of September 11, 2026, Becton, Dickinson and Company (BDX) trades at $176.42. CleaRank Financial AI rates it Hold with a fair value of $197.50, 11.9% above the current price. Wall Street's consensus target is $197.50 across 14 analysts. RSI at 28 is in oversold territory, and the price is above its 50-day average of $171.46.
Becton, Dickinson and Company (BDX)
Becton, Dickinson and Company NYSE
$176.42
-3.380 (-1.88%)
Latest Price
AI Analyst Consensus
59 / 100
Becton, Dickinson and Company (BDX) is currently trading at $176.42, below its analyst median price target of $197.50, suggesting an 11.9% upside potential. The company operates within the Healthcare sector, specifically Medical Instruments & Supplies, with its sector ETF being XLV. Recent earnings reports show mixed performance, with the latest quarter beating estimates by 2.87% but showing a year-over-year revenue decline of 13.00% for the current quarter. The stock's RSI is at 28.46, indicating oversold conditions, and it is trading above its 50-day and 200-day moving averages ($171.46 and $160.22), though below its 20-day EMA.
BDX Price Analysis
Market Metrics
Open
$178.94
Day Range
$175.67 to $178.94
Prev Close
$179.80
Volume
1.68M
52-Week Range
$127.59 to $193.07
Market Cap
$48.05B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Valuation is broadly in line with sector peers (-0.0124% difference), suggesting fair market pricing relative to industry standards.
BDX Analysis
Company's Health
4/5
12-Month Analyst Target
+11.95% Upside
Median of 14 analysts (12-month)
$197.50
AI Technical Analysis
Becton, Dickinson and Company (BDX) is trading above its 50-day and 200-day moving averages ($171.46 and $160.22), indicating a generally positive long-term trend, but is currently below its 20-day EMA, suggesting near-term weakness. The Relative Strength Index (RSI) is at 28.46, signaling oversold conditions that could precede a bounce. MACD is positive at 2.39, but the overall chart structure, combined with moderate insider selling, warrants caution despite the oversold technicals.
ProTips
- Given the moderate insider selling and declining revenue growth, consider a cautious approach to new positions in Becton, Dickinson and Company (BDX) until a clear turnaround in sales is evident.
- The stock's RSI is in oversold territory, suggesting a potential short-term bounce could occur, but this should be viewed with caution given the fundamental headwinds.
- With a dividend yield of 2.12%, Becton, Dickinson and Company (BDX) offers a modest income stream, but investors should prioritize the company's ability to reverse its revenue decline.
Key Catalysts
Bullish
Recent Earnings Beat
Becton, Dickinson and Company (BDX) beat EPS estimates in the latest reported quarter (August 2026) by 2.87%, indicating operational resilience.
Source: Earnings ReportBearish
Moderate Insider Selling
Insiders have sold a net $3.2 million more stock than they purchased in recent transactions, signaling a potential lack of confidence in near-term price appreciation.
Source: Insider TransactionsBearish
Declining Revenue Growth
Current quarter revenue estimates show a projected year-over-year decline of 13.00%, posing a risk to future profitability and valuation.
Source: Wall Street EstimatesNeutral
Trading Above Key Moving Averages
The stock is trading above its 50-day and 200-day moving averages ($171.46 and $160.22), indicating some underlying support, though it is currently below its 20-day EMA.
Source: Technical AnalysisMarket Outlook
However, the current revenue decline and moderate insider selling present significant headwinds that could limit upside potential in the near to medium term. Investors should monitor upcoming earnings reports and revenue trends closely. Insiders are net sellers with $111.9M in total sales versus $1.4M in total purchases in recent filings.
Key Statistics
| Market Cap | 48.05B |
|---|---|
| P/E Ratio | 30.99 |
| EPS (TTM) | 5.78 |
| Dividend Yield | 2.12% |
| 52 Week High | 193.07 |
| 52 Week Low | 127.59 |
Becton, Dickinson and Company (BDX) exhibits a P/E ratio of 30.99, which is in line with the sector average of 30.99, suggesting fair valuation relative to peers. However, the company is experiencing a revenue growth slowdown, with current quarter estimates showing a 13.00% year-over-year decline. While the company has a healthy balance sheet and profitability metrics are generally stable, the declining revenue trend is a concern that tempers the attractiveness of its current valuation.
Earnings & Growth Analysis
Becton, Dickinson and Company (BDX) recently reported earnings that beat estimates, with EPS of $3.23 against an estimate of $3.14 for the August 2026 quarter, a 2.87% surprise. However, this positive earnings surprise did not translate into significant stock price appreciation, with a -0.12% change. The company has a history of beating estimates, but the recent revenue growth has turned negative, indicating potential challenges ahead.
Key Risks
A primary risk for Becton, Dickinson and Company (BDX) is the moderate insider selling, with total sales exceeding purchases by over $3 million, signaling potential concerns among management. Additionally, the company is facing a significant revenue growth slowdown, with current quarter estimates projecting a 13.00% year-over-year decline, which could pressure future earnings and valuation.
Technical Indicators
| RSI (14) | 28.46 |
|---|---|
| MACD | 2.39 |
| SMA 50 | 171.46 |
| SMA 200 | 160.22 |
RSI
Oversold
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($171.46) above the 200-day SMA ($160.22), price action is firmly bullish above key moving averages, RSI at 28.5 suggests oversold conditions; potential bounce setup.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.25
Weak correlation
Nasdaq 100 (QQQ)
+0.12
Weak correlation
Bitcoin (BTC)
-0.02
Weak correlation
Gold (XAU)
+0.09
Weak correlation
Check Custom Correlation
Calculating correlation...
BDX Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$174.66
Slight discount to current
Wait for small dip
AGGRESSIVE
$176.42
At current price
Enter now if confident
Risk Management
STOP LOSS
$168.89
MAX LOSS
-3.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (28.5) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$179.90
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$183.39
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$188.63
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for BDX is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in BDX in September 2016 would be worth about $13,274 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BDX today could grow to about $16,028 by 2036 in the base case, with a bull case near $42,579 and a bear case around $6,034. Projections are statistical simulations, not guarantees.
BDX Stock Price Prediction: 2030
CleaRank's simulation projects a price near $213 for BDX by 2030 in the base case, from $176 today (1.2x over 4 years). The downside path ends near $115. These are outcomes of a Monte Carlo simulation run on BDX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $136 | $185 | $252 |
| 2028 | $125 | $194 | $300 |
| 2029 | $119 | $203 | $347 |
| 2030 | $115 | $213 | $395 |
| 2031 | $112 | $223 | $446 |
| 2032 | $110 | $234 | $499 |
| 2033 | $108 | $245 | $556 |
| 2034 | $107 | $257 | $617 |
| 2035 | $107 | $270 | $682 |
| 2036 | $106 | $283 | $751 |
Method: 10,000 simulated price paths using BDX's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
BDX Insider Trading Analysis
Bought
$1.0M
1 Transactions
Sold
$4.2M
29 Transactions
Insiders
26
Active Traders
Avg Transaction
$172.7K
Moderate size
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jan 27, 2020 | FORLENZA VINCENT A
Chief Executive Officer
|
Sell | 39.0K | $10.9M |
| Jan 10, 2020 | FORLENZA VINCENT A
Chief Executive Officer
|
Sell | 33.5K | $9.2M |
| Jan 2, 2020 | FORLENZA VINCENT A
Chief Executive Officer
|
Sell | 33.4K | $9.1M |
| Jan 28, 2020 | FORLENZA VINCENT A
Chief Executive Officer
|
Sell | 28.5K | $8.0M |
| Aug 9, 2019 | LIM JAMES C
Officer
|
Sell | 23.9K | $6.0M |
| Aug 9, 2022 | KHICHI SAMRAT S
General Counsel
|
Sell | 16.5K | $4.3M |
| Feb 25, 2022 | LARSON BETTY D
Officer
|
Sell | 14.4K | $3.9M |
| May 21, 2019 | KHICHI SAMRAT S
General Counsel
|
Sell | 16.1K | $3.8M |
| Dec 16, 2019 | MAS RIBO ALBERTO
Officer
|
Sell | 11.9K | $3.2M |
| Dec 12, 2019 | FORLENZA VINCENT A
Chief Executive Officer
|
Sell | 11.6K | $3.1M |
Page 1 of 1
Frequently Asked Questions
What is Becton, Dickinson and Company's (BDX) current consensus rating?
Becton, Dickinson and Company (BDX) currently holds a 'Hold' consensus rating from Wall Street analysts. This is based on a breakdown of 1 Strong Buy, 6 Buy, and 7 Hold ratings among the 14 analysts covering the stock.
What is the upside potential for Becton, Dickinson and Company (BDX) stock based on analyst targets?
The median analyst price target for Becton, Dickinson and Company (BDX) is $197.50, suggesting an upside potential of 11.9% from its current price of $176.42.
Are Becton, Dickinson and Company (BDX) insiders buying or selling stock?
Insiders at Becton, Dickinson and Company (BDX) are net sellers of the stock. Total insider sales amounted to $4.2 million, while total purchases were $1 million, resulting in a moderate sell signal.
What are the key risks facing Becton, Dickinson and Company (BDX)?
Key risks for Becton, Dickinson and Company (BDX) include moderate insider selling and a significant slowdown in revenue growth, with current quarter estimates showing a 13.00% year-over-year decline. These factors could impact future profitability and stock performance.
How is Becton, Dickinson and Company (BDX) performing technically?
Technically, Becton, Dickinson and Company (BDX) shows oversold conditions with an RSI at 28.5, and is trading above its 50-day and 200-day moving averages ($171.46 and $160.22). However, it is currently below its 20-day EMA, indicating some near-term weakness.
What is the revenue growth outlook for Becton, Dickinson and Company (BDX)?
The revenue growth outlook for Becton, Dickinson and Company (BDX) is currently challenged, with current quarter estimates projecting a 13.00% year-over-year decline. The next year's growth is estimated at a modest +2.00%.
Is Becton, Dickinson and Company (BDX) stock a buy right now?
Becton, Dickinson and Company (BDX) is currently rated a 'Hold' by Wall Street analysts, with a median price target of $197.50, implying an 11.9% upside. While technically oversold, concerns around revenue slowdown and insider selling suggest caution.